Position in ANTX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$204,700
-$471,771 QoQ
Shares Held
59,854
-89.9% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in ANTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Peapod Lane Capital LLC holds $10,630,434 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCYC |
Bicycle Therapeutics PLC
|
537,978 | $2,281,026 | |
| 2 | ENGN |
enGene Therapeutics Inc.
|
1,102,149 | $1,906,717 | |
| 3 | NKTX |
Nkarta, Inc.
|
549,923 | $1,556,282 | |
| 4 | PLRX |
Pliant Therapeutics, Inc.
|
1,309,013 | $1,492,274 | |
| 5 | FULC |
Fulcrum Therapeutics, Inc.
|
285,798 | $1,046,020 | |
| 6 | ZNTL |
Zentalis Pharmaceuticals, Inc.
|
202,864 | $983,890 | |
| 7 | SEER |
Seer, Inc.
|
445,450 | $739,447 | |
| 8 | MGX |
Metagenomi Therapeutics, Inc.
|
525,024 | $624,778 |
All Filings in ANTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $204,700 | 59,854 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $676,471 | 593,396 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $748,304 | 589,216 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $617,736 | 582,770 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $789,960 | 580,853 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $798,778 | 578,825 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||